25805 Ixekizumab provides more durable improvements in skin clearance, itch, and quality of life than guselkumab in patients with moderate-to-severe psoriasis: 24-week results from IXORA-R
- Resource Type
- Abstract
- Source
- In
Journal of the American Academy of Dermatology September 2021 85(3) Supplement:AB11-AB11 - Subject
- Language
- ISSN
- 0190-9622